Martin Pichler

16.6k total citations · 1 hit paper
310 papers, 11.4k citations indexed

About

Martin Pichler is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Martin Pichler has authored 310 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Oncology, 121 papers in Cancer Research and 119 papers in Molecular Biology. Recurrent topics in Martin Pichler's work include Cancer-related molecular mechanisms research (58 papers), Inflammatory Biomarkers in Disease Prognosis (49 papers) and MicroRNA in disease regulation (44 papers). Martin Pichler is often cited by papers focused on Cancer-related molecular mechanisms research (58 papers), Inflammatory Biomarkers in Disease Prognosis (49 papers) and MicroRNA in disease regulation (44 papers). Martin Pichler collaborates with scholars based in Austria, United States and Germany. Martin Pichler's co-authors include Armin Gerger, Tatjana Stojaković, George A. Călin, Michael Stotz, Joanna Szkandera, Gerald Höefler, Hellmut Samonigg, Karl Pummer, Georg C. Hutterer and Hui Ling and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Martin Pichler

302 papers receiving 11.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer

2013 413 citations Armin Gerger, Florian Eisner et al. British Journal of Cancer profile →

Peers

Countries citing papers authored by Martin Pichler

Since Specialization

Citations

This map shows the geographic impact of Martin Pichler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Pichler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Pichler more than expected).

Fields of papers citing papers by Martin Pichler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Pichler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Pichler. The network helps show where Martin Pichler may publish in the future.

Co-authorship network of co-authors of Martin Pichler

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Pichler. A scholar is included among the top collaborators of Martin Pichler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Pichler. Martin Pichler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	704P Characteristics and palliative management of patients with cisplatin-refractory germ cell tumours: A Global Germ Cell Cancer Collaborative Group (G3) retrospective registry study 2024 ·Annals of Oncology ·Christoph Oing, Christoph Seidel, (unknown), A. Tryakin, Ugo De Giorgi, Hege Sagstuen Haugnes, M. Hentrich, Annette Dieing, Stefanie Zschäbitz, Jourik A. Gietema, (unknown), Christian D. Fankhauser, (unknown), Jorge Aparicio, Margaret Ottaviano, Martin Pichler, (unknown), (unknown), (unknown), Carsten Bokemeyer	0
2	MUG CCArly: A Novel Autologous 3D Cholangiocarcinoma Model Presents an Increased Angiogenic Potential 2023 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), Laura Liesinger, Ruth Birner‐Gruenberger, Wilfried Renner, Martin Pichler, Johannes Grillari, Ariane Aigelsreiter, Beate Rinner	2
3	Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome 2023 ·Cancer Genomics & Proteomics ·Jaroslav Juráček, (unknown), Karolína Trachtová, (unknown), (unknown), Dominik A. Barth, Martin Pichler, Michal Staník, Ondřej Slabý	5
4	A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma 2023 ·Frontiers in Immunology ·Renate Pichler, Peter J. Siska, Piotr Tymoszuk, Agnieszka Martowicz, Gerold Untergasser, Roman Mayr, Florian Weber, Andreas Seeber, Florian Kocher, Dominik A. Barth, Martin Pichler, Martin Thurnher	14
5	Isochromosome 12p Formation Regulates Vitamin D Metabolism in Testicular Cancer 2023 ·Nutrients ·(unknown), (unknown), Martin Pichler, Renate Pichler, Frédéric R. Santer	5
6	T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study 2021 ·British Journal of Cancer ·Maria Anna Smolle, (unknown), (unknown), (unknown), Iva Brčić, Marko Bergovec, Susanne Scheipl, Barbara Prietl, Martin Pichler, Armin Gerger, Christopher Rossmann, Jakob M. Riedl, (unknown), (unknown), Amin El‐Heliebi, Andreas Leithner, Bernadette Liegl‐Atzwanger, Joanna Szkandera	22
7	Trends and Patterns in the Public Awareness of Palliative Care, Euthanasia, and End-of-Life Decisions in 3 Central European Countries Using Big Data Analysis From Google: Retrospective Analysis 2021 ·Journal of Medical Internet Research ·(unknown), (unknown), G Hofmann, Elisabeth Andritsch, (unknown), (unknown), Eva Katharina Masel, Philipp J. Jost, Martin Pichler	8
8	Long Non-Coding RNAs in Biliary Tract Cancer—An Up-to-Date Review 2020 ·Journal of Clinical Medicine ·(unknown), Daniel Neureiter, Markus Ritter, Martin Jakab, Martin Gaisberger, Martin Pichler, Tobias Kiesslich, Christian Mayr	10
9	Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer 2020 ·Genome Medicine ·Qing Zhou, Samantha Perakis, Peter Ulz, Sumitra Mohan, Jakob M. Riedl, Emina Talakić, Sigurd Lax, Martin Tötsch, Gerald Höefler, Thomas Bauernhofer, Martin Pichler, Armin Gerger, Jochen B. Geigl, Ellen Heitzer, Michael R. Speicher	28
10	Stage-Specific Value of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Serum Levels on Survival and Recurrence in Pancreatic Cancer: A Single Center Study and Meta-Analysis 2020 ·Cancers ·Labrinus van Manen, Jesse V. Groen, Hein Putter, Martin Pichler, Alexander L. Vahrmeijer, Bert A. Bonsing, J. Sven D. Mieog	18
11	Long non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk 2018 ·Cancer Letters ·Filippo Del Vecchio, (unknown), (unknown), Rahul Bhome, S. Pugh, Emre Sayan, Gareth J. Thomas, Graham Packham, John Primrose, Martin Pichler, Alexander Mirnezami, George A. Călin, Marc D. Bullock	22
12	NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes 2017 ·Cancer Research ·Alexander Deutsch, Beate Rinner, Martin Pichler, Katharina Prochazka, (unknown), (unknown), Karoline Fechter, Stefan Hatzl, Julia Feichtinger, Kerstin Wenzl, (unknown), Verena Stiegelbauer, Andreas Prokesch, Anne Krogsdam, Heinz Sill, Gerhard Thallinger, Hildegard Greinix, Chenguang Wang, Christine Beham‐Schmid, Peter Neumeister	22
13	Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells 2016 ·Cancer Research ·Pınar Kanlikilicer, Mohammed H. Rashed, Recep Bayraktar, Rahul Mitra, Cristina Ivan, Burcu Aslan, Xinna Zhang, Justyna Filant, Andreia Silva, Cristian Rodriguez‐Aguayo, Emine Bayraktar, Martin Pichler, Bülent Özpolat, George A. Călin, Anil K. Sood, Gabriel Lopez‐Berestein	118
14	Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP 2016 ·Cancer Research ·Stefan Hatzl, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rotraud Wieser, Martin Pichler, Marcel Scheideler, (unknown), Mojca Jongen‐Lavrencic, Franz Quehenberger, Albert Wölfler, Jakob Troppmair, Heinz Sill, Armin Zebisch	39
15	Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis 2016 ·Clinical Cancer Research ·Martin Pichler, Verena Stiegelbauer, Petra Vychytilova‐Faltejskova, Cristina Ivan, Hui Ling, Elke Winter, Xinna Zhang, (unknown), Annika Wulf-Goldenberg, Masahisa Ohtsuka, Johannes Haybaeck, Marek Svoboda, Yoshinaga Okugawa, Armin Gerger, Gerald Höefler, Ajay Goel, Ondřej Slabý, George A. Călin	61
16	Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer 2016 ·Nature Communications ·Peter Ulz, Jelena Belic, Ricarda Graf, Martina Auer, Ingrid Lafer, Katja Fischereder, Gerald Webersinke, Karl Pummer, Herbert Augustin, Martin Pichler, Gerald Höefler, Thomas Bauernhofer, Jochen B. Geigl, Ellen Heitzer, Michael R. Speicher	110
17	Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma 2015 ·Journal of Clinical Pathology ·Orietta Dalpiaz, Martin Pichler, (unknown), D. Reitz, Daniel Krieger, (unknown), Angelika Bezan, Tatjana Stojaković, Karl Pummer, Richard Zigeuner, Georg C. Hutterer	11
18	MiR‐96‐5p influences cellular growth and is associated with poor survival in colorectal cancer patients 2014 ·Molecular Carcinogenesis ·Anna Lena Ress, Verena Stiegelbauer, Elke Winter, Daniela Schwarzenbacher, Tobias Kiesslich, Sigurd Lax, (unknown), Alexander Deutsch, Thomas Bauernhofer, Hui Ling, Hellmut Samonigg, Armin Gerger, Gerald Höefler, Martin Pichler	68
19	miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor 2013 ·Journal of Clinical Pathology ·Martin Pichler, Elke Winter, Anna Lena Ress, Thomas Bauernhofer, Armin Gerger, Tobias Kiesslich, Sigurd Lax, Hellmut Samonigg, Gerald Höefler	83
20	Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing 2013 ·Cancer Research ·Ellen Heitzer, Martina Auer, Christin Gasch, Martin Pichler, Peter Ulz, Eva Maria Hoffmann, Sigurd Lax, Julie Waldispuehl‐Geigl, Oliver Mauermann, Carolin Lackner, Gerald Höfler, Florian Eisner, Heinz Sill, Hellmut Samonigg, Klaus Pantel, Sabine Riethdorf, Thomas Bauernhofer, Jochen B. Geigl, Michael R. Speicher	403

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact